In 2024, the import of blood-grouping reagents to the US is forecasted to reach 316.28 thousand kilograms, marking a significant rise from the year 2023 baseline which stood at approximately 302 thousand kilograms. Projections show a steady increase over the next few years, reaching 369.99 thousand kilograms by 2028. This reflects a continuous year-on-year growth in the forecast period, with the compound annual growth rate (CAGR) highlighting consistent expansion in demand.

Future trends to watch for:

Innovations in blood testing technology may impact reagent requirements.
Regulatory changes potentially influencing import volumes and sourcing strategies.
Impact of global supply chain dynamics on reagent availability and pricing.